Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 720 participants.

Also called NCT07415642

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 720 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07415642
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07415642. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2032-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)
Acronym
DUTCH-ICD
Condition
Sudden Cardiac Death
Intervention (Device)
ICD implantation
Lead sponsor
University Medical Center Groningen (class: other)
Collaborator
Amsterdam University Medical Center (class: other)
Collaborator
Radboud University Medical Center (class: other)

Record details

Record id
cardio:ct-nct07415642
Content hash
18d5a290a5abfeb6810b9f3793e009f1eb69b4b7d8d1b67e5b97e6eb0b807a19